Milan, Italy

Matteo Iannacone

USPTO Granted Patents = 19 

 

Average Co-Inventor Count = 8.6

ph-index = 13

Forward Citations = 512(Granted Patents)


Location History:

  • Boston, MA (US) (2012 - 2020)
  • Milan, IT (2014 - 2023)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
19 patents (USPTO):

Title: Matteo Iannacone: Innovator in Vaccine Nanotechnology and Hepatitis B Treatments

Introduction

Matteo Iannacone is a distinguished inventor based in Milan, Italy, renowned for his groundbreaking contributions to the fields of vaccine nanotechnology and viral inhibition. With a robust portfolio of 18 patents, Iannacone's work focuses on advanced methods for delivering therapeutic agents that stimulate immune responses and combat infectious diseases.

Latest Patents

Iannacone's latest innovations include a significant patent for vaccine nanotechnology. This invention details compositions and systems designed for the delivery of nanocarriers to immune system cells. The vaccine nanocarriers he developed are capable of stimulating immune responses in T cells and B cells, incorporating immunomodulatory agents and potentially immunostimulatory agents. Furthermore, it outlines methods for prophylaxis and treatment of diseases through the administration of these nanocarriers.

Another notable patent addresses tricyclic inhibitors of the Hepatitis B virus (HBV). This invention presents compounds effective in inhibiting HBV, which may be used alone or in conjunction with other agents to treat, prevent, or ameliorate HBV infection and its related conditions. It also includes pharmaceutical compositions containing these innovative compounds.

Career Highlights

Iannacone has had a remarkable career, collaborating with prestigious institutions such as Harvard College and the Massachusetts Institute of Technology (MIT). His academic and research endeavors at these renowned universities have significantly bolstered his expertise and innovations in the biomedical field.

Collaborations

Throughout his career, Iannacone has collaborated with notable colleagues, including Elliott Ashley Moseman and Ulrich Von Andrian. These partnerships have been integral to enhancing the scope and impact of his research, contributing to advancements in therapeutic technologies and delivery systems.

Conclusion

Matteo Iannacone's innovative work in vaccine nanotechnology and Hepatitis B virus treatment exemplifies the potential of modern science to combat pressing health challenges. His contributions through numerous patents pave the way for future advancements in immunotherapy and viral inhibition, establishing him as a leading figure in biomedical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…